Atlas Trials

A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections

Clinical trial NCT07063095 · RECRUITING

Trial details

NCT number
NCT07063095
Sponsor
Angela HUTTNER
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Gram Negative InfectionsSepsis and Septic Shock
Start date
2025-08-25
Primary completion
2026-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.